title: [Estimation of clinical-pathogenetic efficiency of reamberin and cycloferon application in patients with the severe form of acute tonsillitis].
abstract: Efficiency of reamberin and cycloferon application combination at the patients with the heavy form of acute tonsillitis was investigated. It is set that cycloferon and reamberin application in the complex of treatment of the patients with this pathology is instrumental in normalization of the general state and feel of patients, liquidation of both commontoxic syndrome and local inflammatory displays in pharynx, and also normalization of the studied biochemical and immunological indexes. Application of cycloferon and reamberin provides the decline of "average molecules" and malon dialdehyde level to norm, that testifies about liquidation endogenous "metabolic" intoxication syndrome, and also instrumental in normalization of phagocytes activity of monocytes indexes, that describe normalize operating of the indicated preparation on the macrophage phagocytes system.
authors.forename: V M
authors.initials: VM
authors.lastname: Frolov
authors.forename: V A
authors.initials: VA
authors.lastname: Tereshkin
authors.forename: Ia A
authors.initials: IaA
authors.lastname: Sotskaia
authors.forename: N A
authors.initials: NA
authors.lastname: Peresadin
authors.forename: O V
authors.initials: OV
authors.lastname: Kruglova
mesh_terms: D000166:Acridines / Q000008:administration & dosage / Q000627:therapeutic use*; D000208:Acute Disease; D000328:Adult; D000975:Antioxidants / Q000008:administration & dosage / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007369:Interferon Inducers / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D008536:Meglumine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D008875:Middle Aged; D012720:Severity of Illness Index; D013386:Succinates / Q000008:administration & dosage / Q000627:therapeutic use*; D014069:Tonsillitis / Q000097:blood / Q000188:drug therapy* / Q000209:etiology / Q000276:immunology; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D000166:Acridines; D000975:Antioxidants; D007369:Interferon Inducers; C549374:Reamberin; D013386:Succinates; D008536:Meglumine; C026430:10-carboxymethyl-9-acridanone